Press releases

December 20, 2017
Regulatory

New major order from China

Bactiguard has received a new order from China of 100 000 urinary catheters for infection prevention, which will be delivered in December and generate revenues of some 3 million SEK.

November 22, 2017

Bactiguard's endotracheal tubes approved in India

The product approval for Bactiguard's endotracheal tubes has been announced by the Indian Ministry of Health & Family Welfare. This means that Bactiguard can offer its complete portfolio of products for effective and safe infection prevention in one of the largest and fastest growing markets in the world. 

November 20, 2017

Nomination Committee appointed for the Annual General Meeting 2018

The Annual General Meeting of Bactiguard Holding AB (publ) will be held on Wednesday 16 May, 2018 in Botkyrka. 

November 10, 2017

New clinical study shows fewer adverse events with Bactiguard's central venous catheter compared to a standard central venous catheter

A recently published clinical study* conducted at the Karolinska University Hospital in Sweden shows that Bactiguard’s infection prevention central venous catheter – BIP CVC had significantly fewer adverse events compared to a standard uncoated CVC. The study also shows that Bactiguard's noble metal alloy does not expose patients or the environment to any risks in blood applications.

November 09, 2017
Regulatory

Interim report for Q3 2017

We can now put eight quarters of rising sales, based on rolling twelve-month figures, behind us. Volumes are increasing and as we expand the product offerings in the markets where we are already established, the value of sales increases through an improved product mix. At the same time, we are increasing our presence in new, strategically important markets. Our own product portfolio now accounts for approx. 15 percent of sales.

November 08, 2017
Regulatory

Bactiguard secures three-year financing

Bactiguard has received a commitment for a three-year credit facility of SEK 180 million from Skandinaviska Enskilda Banken (SEB), in the form of an overdraft facility of SEK 30 million and a term loan of SEK 150 million. The credit facility replaces current bank financing as well as a loan from the company's main shareholders.

November 06, 2017

Invitation to presentation of Bactiguard's interim report on November 9, 2017

Bactiguard Holding AB (publ) publishes the interim report for the third quarter on Thursday, November 9, 2017 at 8:00 CET.

November 06, 2017

Bactiguard enters new partnership in India

Bactiguard has entered a partnership with Neon Laboratories Limited (“Neon”) for the north, west and east zones of India, covering a majority of the Indian population. 

October 27, 2017

Bactiguard wins another tender in Sweden

Bactiguard has won a tender for urinary catheters for the Västra Götaland region (VGR) in Sweden, which enables healthcare providers in both primary and secondary care and 49 municipalities in the region to purchase Bactiguards’ urinary catheters for infection prevention. The contract is valid for 2 years and can be extended for another 2 years.

October 04, 2017

Bactiguard's central venous catheters approved in Hong Kong

The Hong Kong product approval for Bactiguard's central venous catheters for infection prevention has been announced by the Medical Device Control Office. Hong Kong is a small, but strategically important market, as it serves as a reference for new approvals and market acceptance in neighbouring China. 

Pages